Fiorella L. Roldán, Mercedes Ingelmo-Torres, Claudia Mercader, Marcel Figueras, Bernat Padullés, María Angeles Durán, Josep L. Carrasco, María José Ribal, Agustín Franco, Laura Izquierdo, Antonio Alcaraz, Lourdes Mengual
{"title":"膀胱EpiCheck用于预测非肌浸润性膀胱癌患者卡介苗应答的临床应用","authors":"Fiorella L. Roldán, Mercedes Ingelmo-Torres, Claudia Mercader, Marcel Figueras, Bernat Padullés, María Angeles Durán, Josep L. Carrasco, María José Ribal, Agustín Franco, Laura Izquierdo, Antonio Alcaraz, Lourdes Mengual","doi":"10.1111/bju.16697","DOIUrl":null,"url":null,"abstract":"To evaluate the performance of Bladder Epicheck® (BE; Nucleix Ltd., Rehovot, Israel) in predicting tumour recurrence and bacillus Calmette–Guérin (BCG) failure during the first year after induction treatment.","PeriodicalId":8985,"journal":{"name":"BJU International","volume":"25 1","pages":""},"PeriodicalIF":3.7000,"publicationDate":"2025-03-06","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":"{\"title\":\"Bladder EpiCheck clinical utility to predict BCG response in non-muscle-invasive bladder cancer\",\"authors\":\"Fiorella L. Roldán, Mercedes Ingelmo-Torres, Claudia Mercader, Marcel Figueras, Bernat Padullés, María Angeles Durán, Josep L. Carrasco, María José Ribal, Agustín Franco, Laura Izquierdo, Antonio Alcaraz, Lourdes Mengual\",\"doi\":\"10.1111/bju.16697\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"To evaluate the performance of Bladder Epicheck® (BE; Nucleix Ltd., Rehovot, Israel) in predicting tumour recurrence and bacillus Calmette–Guérin (BCG) failure during the first year after induction treatment.\",\"PeriodicalId\":8985,\"journal\":{\"name\":\"BJU International\",\"volume\":\"25 1\",\"pages\":\"\"},\"PeriodicalIF\":3.7000,\"publicationDate\":\"2025-03-06\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"BJU International\",\"FirstCategoryId\":\"3\",\"ListUrlMain\":\"https://doi.org/10.1111/bju.16697\",\"RegionNum\":2,\"RegionCategory\":\"医学\",\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"Q1\",\"JCRName\":\"UROLOGY & NEPHROLOGY\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"BJU International","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.1111/bju.16697","RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q1","JCRName":"UROLOGY & NEPHROLOGY","Score":null,"Total":0}
Bladder EpiCheck clinical utility to predict BCG response in non-muscle-invasive bladder cancer
To evaluate the performance of Bladder Epicheck® (BE; Nucleix Ltd., Rehovot, Israel) in predicting tumour recurrence and bacillus Calmette–Guérin (BCG) failure during the first year after induction treatment.
期刊介绍:
BJUI is one of the most highly respected medical journals in the world, with a truly international range of published papers and appeal. Every issue gives invaluable practical information in the form of original articles, reviews, comments, surgical education articles, and translational science articles in the field of urology. BJUI employs topical sections, and is in full colour, making it easier to browse or search for something specific.